SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Millennium: The Takeda Oncology Company and Seattle Genetics, Inc. Initiate Global Phase 3 Clinical Trial of ADCETRIS® in Previously Untreated Advanced Hodgkin Lymphoma